NanoLogix Inc (NNLX)

[exploremore]

"based upon preliminary development work done for detection of proteins associated with Ebola in 2014',"
" it may not be viewed as worthwhile in a cost:benefit analysis by various agencies or institutions."

As far as I know there is as little known about the Ebola test as there is about the covid test. Is the covid test is based on the same idea? If that is the case the statement, "it may not be viewed as worthwhile", would seem to stem from what was learned during the preliminary development work on Ebola.

Did they not follow up simply because Ebola faded out or it was found to be viewed to be not worthwhile.

I hear the covid test to be released is 100% accurate on the MBs. What has NNLX claimed?